From: HPV-specific risk assessment of cervical cytological abnormalities
Genotypes | P | OR (for LCT (+)) | 95%CI |
---|---|---|---|
HPV-16 | < 0.001 | 4.591 | 3.17–6.66 |
HPV-18 | 0.036 | 2.021 | 1.05–3.90 |
HPV-33 | 0.001 | 3.165 | 1.61–6.22 |
HPV-39 | 0.002 | 2.841 | 1.47–5.50 |
HPV-45 | 0.025 | 13.775 | 1.40–135.92 |
HPV-51 | 0.002 | 4.765 | 1.80–12.63 |
HPV-52 | < 0.001 | 3.623 | 2.54–5.17 |
HPV-53 | < 0.001 | 3.796 | 2.20–6.54 |
HPV-56 | 0.001 | 5.747 | 2.13–15.52 |
HPV-58 | < 0.001 | 5.034 | 3.27–7.76 |
HPV-59 | 0.001 | 5.838 | 2.11–16.13 |
HPV-66 | < 0.001 | 6.001 | 2.55–14.14 |
HPV-68 | 0.027 | 2.299 | 1.10–4.80 |
HPV-11 | 0.009 | 3.21 | 1.34–7.70 |
HPV-42 | 0.039 | 11.811 | 1.14–122.64 |
cp8304 | < 0.001 | 2.984 | 1.62–5.51 |
age | |||
21–30 | 0.001 | 1 | |
31–40 | 0.015 | 1.727 | 1.11–2.69 |
41–50 | 0.736 | 1.076 | 0.70–1.65 |
> 50 | 0.915 | 0.975 | 0.62–1.54 |